New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria

Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria

ProstaLund has signed an agreement on CoreTherm® with MR Prof. Dr Karl Diehl. The agreement means that MR Prof. Dr Karl Diehl has purchased a CoreTherm® machine and that ProstaLund will educate, sell instruments for CoreTherm® treatments and service the machine. The first CoreTherm® treatments are planned to be performed during the third quarter.

‘It is great news that we are now taking the step into Europe in line with the company's presented strategy, and that we get the opportunity to show and train future new customers in a central location in Europe’ says Anders Kristensson, CEO ProstaLund AB.

About ProstaLund

ProstaLund AB (publ) is a Swedish medtech company with a headquartered in Lund that develops and markets innovative products for the treatment of Benign Prostatic Enlargement. The company has patented the CoreTherm® Concept treatment method, a customised thermal treatment for BPE (Benign Prostatic Enlargement). ProstaLund is listed on Nasdaq First North Growth Market and has approximately 4,000 shareholders. See also - www.prostalund.se. Our press releases are also available to read and download here: www.prostalund.se/pressmeddelanden

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

Datum	2024-05-31, kl 10:40
Källa	MFN

Bifogade filer

New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria

LOGGA IN

ProstaLund

New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria